Hillary Clinton All Bark, No Bite with Biotech Tweet
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- U.S. chip stocks extend losses on AI financing, China competition fears
- Tesla to buy power from Arizona solar project
- Why BofA says July Fed rate hike would be "unprecedented"
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
Market Reaction to Clinton Proposals Seen as 'Premature' and 'Overdone' - TD Securities (VRX)
September 23, 2015 11:42 AM EDTTD Securities maintained a Buy rating on Valeant Pharmaceuticals (NYSE: VRX) with a price target of $300. Analyst Lennox Gibbs called the market's reaction to proposals from presidential candidate Hillary Clinton premature and overdone.
Gibbs views plans to authorize Medicare to negotiate prices with drug manufacturers as the most noteworthy of Clinton's proposals, and he pointed out that Valeant derives an estimated 1520% of its revenues from Medicare.
"Drug stocks are down 3% since... More
Hillary Clinton Tweet Doesn't Change Bullish View on Valeant Pharmaceuticals (VRX), BMO Capital Says
September 21, 2015 1:57 PM EDTBMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More
UPDATE: Biotech Bounces Off Lows (IBB)
September 21, 2015 1:19 PM EDT(Updated - September 21, 2015 1:29 PM EDT)
Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More
